NO2005020I1 - Caspofungin, eventuelt i form av et farmasøytisk akseptabelt salt særlig caspofunginacetat - Google Patents
Caspofungin, eventuelt i form av et farmasøytisk akseptabelt salt særlig caspofunginacetatInfo
- Publication number
- NO2005020I1 NO2005020I1 NO2005020C NO2005020C NO2005020I1 NO 2005020 I1 NO2005020 I1 NO 2005020I1 NO 2005020 C NO2005020 C NO 2005020C NO 2005020 C NO2005020 C NO 2005020C NO 2005020 I1 NO2005020 I1 NO 2005020I1
- Authority
- NO
- Norway
- Prior art keywords
- caspofungin
- optionally
- pharmaceutically acceptable
- acceptable salt
- acetate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Chemical Vapour Deposition (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/032,847 US5378804A (en) | 1993-03-16 | 1993-03-16 | Aza cyclohexapeptide compounds |
PCT/US1994/002580 WO1994021677A1 (en) | 1993-03-16 | 1994-03-10 | Aza cyclohexapeptide compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO2005020I1 true NO2005020I1 (no) | 2005-09-13 |
NO2005020I2 NO2005020I2 (no) | 2008-12-01 |
Family
ID=21867140
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19953648A NO318372B1 (no) | 1993-03-16 | 1995-09-15 | Azasykloheksapeptidforbindelser, antimikrobielt preparat og anvendelse av disse forbindelser ved fremstilling av et farmasoytisk preparat. |
NO2005020C NO2005020I2 (no) | 1993-03-16 | 2005-09-13 | Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19953648A NO318372B1 (no) | 1993-03-16 | 1995-09-15 | Azasykloheksapeptidforbindelser, antimikrobielt preparat og anvendelse av disse forbindelser ved fremstilling av et farmasoytisk preparat. |
Country Status (33)
Country | Link |
---|---|
US (3) | US5378804A (no) |
EP (1) | EP0620232B1 (no) |
JP (1) | JP2568474B2 (no) |
KR (1) | KR100329693B1 (no) |
CN (1) | CN1098274C (no) |
AT (1) | ATE186736T1 (no) |
AU (1) | AU668804B2 (no) |
BG (1) | BG63047B1 (no) |
BR (2) | BR9406009A (no) |
CA (1) | CA2118757C (no) |
CZ (1) | CZ286235B6 (no) |
DE (2) | DE69421639T2 (no) |
DK (1) | DK0620232T3 (no) |
ES (1) | ES2139043T3 (no) |
FI (1) | FI109542B (no) |
GR (1) | GR3031872T3 (no) |
HK (1) | HK1008674A1 (no) |
HR (1) | HRP940161B1 (no) |
HU (2) | HU217614B (no) |
IL (1) | IL108892A (no) |
LU (1) | LU90875I2 (no) |
LV (1) | LV12574B (no) |
NL (1) | NL300076I2 (no) |
NO (2) | NO318372B1 (no) |
NZ (1) | NZ263360A (no) |
PL (1) | PL179261B1 (no) |
RO (1) | RO113246B1 (no) |
RU (1) | RU2122548C1 (no) |
SI (1) | SI9420013B (no) |
SK (1) | SK282527B6 (no) |
UA (1) | UA59329C2 (no) |
WO (1) | WO1994021677A1 (no) |
ZA (1) | ZA941807B (no) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874403A (en) * | 1992-10-15 | 1999-02-23 | Merck & Co., Inc. | Amino acid conjugates of cyclohexapeptidyl amines |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5948753A (en) * | 1993-05-04 | 1999-09-07 | Merck & Co., Inc. | Cyclohexapeptidyl propanolamine compounds |
EP0779895B1 (en) * | 1994-08-23 | 1999-11-17 | Merck & Co. Inc. | An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
ATE223226T1 (de) * | 1994-09-16 | 2002-09-15 | Merck & Co Inc | Azazyklohexapeptid-verbindungen |
US5514651A (en) * | 1994-09-16 | 1996-05-07 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
AU691743B2 (en) * | 1995-01-26 | 1998-05-21 | Merck & Co., Inc. | Novel antifungal cyclohexapeptides |
US5552521A (en) * | 1995-02-10 | 1996-09-03 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
AU707664B2 (en) * | 1995-11-09 | 1999-07-15 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5952300A (en) * | 1996-04-19 | 1999-09-14 | Merck & Co., Inc. | Antifungal compositions |
PE63998A1 (es) * | 1996-04-19 | 1998-10-30 | Merck & Co Inc | Composiciones anti-fungosas |
HRP970318B1 (en) * | 1996-06-14 | 2002-06-30 | Merck & Co Inc | A process for preparing certain aza cyclohexapeptides |
USRE38984E1 (en) * | 1996-09-12 | 2006-02-14 | Merck & Co., Inc. | Antifungal combination therapy |
DE69724626T2 (de) * | 1996-09-12 | 2004-07-29 | Merck & Co., Inc. | Fungizide kombinationstherapie |
US5854212A (en) * | 1996-10-23 | 1998-12-29 | Merck & Co., Inc. | Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
US5936062A (en) * | 1997-06-12 | 1999-08-10 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
JP2003505468A (ja) * | 1999-07-27 | 2003-02-12 | アヴェンティス ファルマ ドイチェラント ゲーエムベーハー | 新規なシクロヘキサペプチド化合物、それらの製造方法及びそれらの医薬品としての使用 |
WO2003079972A2 (en) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
AR035808A1 (es) * | 2001-04-12 | 2004-07-14 | Merck & Co Inc | Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas |
US7214768B2 (en) * | 2002-04-08 | 2007-05-08 | Merck & Co., Inc. | Echinocandin process |
JP4664912B2 (ja) * | 2003-07-22 | 2011-04-06 | セラヴァンス, インコーポレーテッド | グリコペプチド抗菌剤と組み合わせたエキノカンジン抗真菌剤の使用 |
EP1730180A4 (en) * | 2004-02-24 | 2008-06-18 | Commw Scient Ind Res Org | ANTIFUNGAL PEPTIDES |
EP1785432A1 (en) * | 2005-11-15 | 2007-05-16 | Sandoz AG | Process and intermediates for the synthesis of caspofungin. |
JP5373606B2 (ja) * | 2006-07-26 | 2013-12-18 | サンド・アクチエンゲゼルシヤフト | カスポファンギン製剤 |
TW200826957A (en) * | 2006-10-16 | 2008-07-01 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Purification processes for echinocandin-type compounds |
US20100137197A1 (en) * | 2007-06-26 | 2010-06-03 | Sachin Mittal | Lyophilized anti-fungal composition |
US20090075870A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched caspofungin |
WO2009142761A1 (en) * | 2008-05-21 | 2009-11-26 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Caspofungin bo free of caspofungin co |
US8048853B2 (en) * | 2008-06-13 | 2011-11-01 | Xellia Pharmaceuticals Aps | Process for preparing pharmaceutical compound and intermediates thereof |
EP2240507A2 (en) * | 2008-06-25 | 2010-10-20 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Processes for preparing high purity aza cyclohexapeptides |
KR20110011704A (ko) * | 2008-06-25 | 2011-02-08 | 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 | 카스포펀진 불순물 a를 함유하지 않는 카스포펀진 |
WO2010064219A1 (en) | 2008-12-04 | 2010-06-10 | Ranbaxy Laboratories Limited | Process for the preparation of a novel intermediate for caspofungin |
TW201024322A (en) * | 2008-12-31 | 2010-07-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate |
WO2010108637A1 (en) | 2009-03-27 | 2010-09-30 | Axellia Pharmaceuticals Aps | Crystalline compound |
CN101602795B (zh) * | 2009-07-20 | 2011-12-21 | 中国人民解放军第二军医大学 | 环六脂肽胺类抗真菌化合物及其盐类和制备方法 |
EP2463293A4 (en) * | 2009-08-06 | 2013-06-05 | Shanghai Techwell Biopharm Co | AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE |
US8751760B2 (en) * | 2009-10-01 | 2014-06-10 | Dell Products L.P. | Systems and methods for power state transitioning in an information handling system |
CN101792486A (zh) * | 2010-04-12 | 2010-08-04 | 浙江海正药业股份有限公司 | 一种合成醋酸卡泊芬净的方法 |
CN102219832B (zh) * | 2010-04-15 | 2013-08-21 | 上海天伟生物制药有限公司 | 一种氮杂环六肽或其盐的纯化方法 |
UA111599C2 (uk) | 2010-09-20 | 2016-05-25 | Кселлія Фармасьютікалз Апс | Композиція каспофунгіну |
US8927690B2 (en) * | 2010-09-29 | 2015-01-06 | Shanghai Techwell Biopharmaceutical Co., Ltd. | Process for purifying cyclolipopeptide compounds or the salts thereof |
KR101514904B1 (ko) * | 2010-09-30 | 2015-04-23 | 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 | 사이클릭 리포펩타이드 화합물 또는 그의 염의 정제방법 |
CN102367267B (zh) | 2010-11-10 | 2013-09-04 | 上海天伟生物制药有限公司 | 一种卡泊芬净的制备方法 |
CN102367268B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其用途 |
CN102367269B (zh) | 2010-11-10 | 2013-11-06 | 上海天伟生物制药有限公司 | 一种卡泊芬净类似物及其制备方法和用途 |
KR101331984B1 (ko) | 2010-12-09 | 2013-11-25 | 종근당바이오 주식회사 | 카스포펀진 제조방법 및 그의 신규 중간체 |
WO2012093293A1 (en) * | 2011-01-03 | 2012-07-12 | Biocon Limited | Process for preparation of caspofungin acetate and intermediates |
CN102618606B (zh) * | 2011-01-30 | 2014-09-10 | 浙江海正药业股份有限公司 | 一种棘白菌素生物转化方法 |
PT2680873T (pt) | 2011-03-03 | 2017-11-01 | Cidara Therapeutics Inc | Agentes antifúngicos e suas utilizações |
CN102746384B (zh) | 2011-04-22 | 2016-01-20 | 上海天伟生物制药有限公司 | 一种高纯度的卡泊芬净或其盐及其制备方法和用途 |
US9321779B2 (en) | 2011-04-28 | 2016-04-26 | Unitris Biopharma Co., Ltd. | Intermediate for synthesizing caspofungin and preparation method thereof |
RS59960B1 (sr) | 2012-03-19 | 2020-03-31 | Cidara Therapeutics Inc | Dozni režimi za jedinjenja klase ehinokandina |
US9636407B2 (en) * | 2012-11-20 | 2017-05-02 | Fresenius Kabi Usa, Llc | Caspofungin acetate formulations |
CN112110991A (zh) * | 2014-12-24 | 2020-12-22 | 上海天伟生物制药有限公司 | 一种含氮杂环六肽前体的组合物及其制备方法和用途 |
WO2017034961A1 (en) | 2015-08-21 | 2017-03-02 | Trilogy Therapeutics, Inc. | Methods of treating lung infection with caspofungin |
US10369188B2 (en) | 2016-01-08 | 2019-08-06 | Cidara Therapeutics, Inc. | Methods for preventing and treating pneumocystis infections |
WO2017161016A1 (en) | 2016-03-16 | 2017-09-21 | Cidara Therapeutics, Inc. | Dosing regimens for treatment of fungal infections |
WO2017185030A1 (en) * | 2016-04-22 | 2017-10-26 | Fresenius Kabi Usa, Llc | Caspofungin formulation with low impurities |
CA3069423A1 (en) | 2017-07-12 | 2019-01-17 | Cidara Therapeutics, Inc. | Formulations for the treatment of fungal infections |
WO2019157453A1 (en) | 2018-02-12 | 2019-08-15 | Trilogy Therapeutics, Inc. | Caspofungin compositions for inhalation |
EP3620462A1 (en) | 2018-09-04 | 2020-03-11 | Xellia Pharmaceuticals ApS | Process for the preparation of caspofungin |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE851310A (fr) * | 1976-02-12 | 1977-08-10 | Sandoz Sa | Nouveaux derives de la tetrahydro-equinocandine b |
DE2704030A1 (de) * | 1976-02-12 | 1977-08-18 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
DE2742435A1 (de) * | 1976-09-28 | 1978-04-06 | Sandoz Ag | Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung |
US4287120A (en) * | 1979-12-13 | 1981-09-01 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
EP0030844A1 (en) * | 1979-12-13 | 1981-06-24 | Eli Lilly And Company | Recovery process for A-30912 antibiotics |
US4320053A (en) * | 1979-12-13 | 1982-03-16 | Eli Lilly And Company | Derivatives of A-30912D nucleus |
US4293489A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4293485A (en) * | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of S31794/F-1 nucleus |
DE3030554A1 (de) * | 1980-08-13 | 1982-03-25 | Chemische Werke Hüls AG, 4370 Marl | Einbrennlacke |
US4931352A (en) * | 1987-10-07 | 1990-06-05 | Merck & Co., Inc. | Antifungal fermentation product |
US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
US5021341A (en) * | 1990-03-12 | 1991-06-04 | Merck & Co., Inc. | Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol |
US5202309A (en) * | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
IL94862A (en) * | 1989-06-30 | 1994-10-07 | Merck & Co Inc | History of Echinocandin Antifungal Antibiotics, Its Production and Pharmaceutical Preparations Containing It |
US5194377A (en) * | 1989-06-30 | 1993-03-16 | Merck & Co., Inc. | Antibiotic agent |
GB8925593D0 (en) * | 1989-11-13 | 1990-01-04 | Fujisawa Pharmaceutical Co | Fr901379 substance and preparation thereof |
US5159059A (en) * | 1990-05-29 | 1992-10-27 | Merck & Co., Inc. | Process for reduction of certain cyclohexapeptide compounds |
IL105048A (en) * | 1992-03-19 | 2001-06-14 | Eli Lilly And Company U S | Antifungal substances of the cyclic peptide type and a process for their preparation |
US5378804A (en) * | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
US5516757A (en) * | 1994-09-16 | 1996-05-14 | Merck & Co., Inc. | Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
US5516756A (en) * | 1994-10-31 | 1996-05-14 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
-
1993
- 1993-03-16 US US08/032,847 patent/US5378804A/en not_active Expired - Lifetime
-
1994
- 1994-03-08 IL IL10889294A patent/IL108892A/en not_active IP Right Cessation
- 1994-03-09 ES ES94200604T patent/ES2139043T3/es not_active Expired - Lifetime
- 1994-03-09 EP EP94200604A patent/EP0620232B1/en not_active Expired - Lifetime
- 1994-03-09 DE DE69421639T patent/DE69421639T2/de not_active Expired - Lifetime
- 1994-03-09 DK DK94200604T patent/DK0620232T3/da active
- 1994-03-09 DE DE10299013C patent/DE10299013I2/de active Active
- 1994-03-09 AT AT94200604T patent/ATE186736T1/de active
- 1994-03-10 BR BR9406009A patent/BR9406009A/pt not_active Application Discontinuation
- 1994-03-10 HR HR940161A patent/HRP940161B1/xx not_active IP Right Cessation
- 1994-03-10 SK SK1136-95A patent/SK282527B6/sk not_active IP Right Cessation
- 1994-03-10 PL PL94310634A patent/PL179261B1/pl unknown
- 1994-03-10 HU HU9502703A patent/HU217614B/hu unknown
- 1994-03-10 RU RU95121639A patent/RU2122548C1/ru active
- 1994-03-10 CA CA002118757A patent/CA2118757C/en not_active Expired - Lifetime
- 1994-03-10 RO RO95-01594A patent/RO113246B1/ro unknown
- 1994-03-10 KR KR1019950703954A patent/KR100329693B1/ko active IP Right Grant
- 1994-03-10 WO PCT/US1994/002580 patent/WO1994021677A1/en active IP Right Grant
- 1994-03-10 SI SI9420013A patent/SI9420013B/sl unknown
- 1994-03-10 CN CN94191487A patent/CN1098274C/zh not_active Expired - Lifetime
- 1994-03-10 CZ CZ19952358A patent/CZ286235B6/cs not_active IP Right Cessation
- 1994-03-10 NZ NZ263360A patent/NZ263360A/xx not_active IP Right Cessation
- 1994-03-15 ZA ZA941807A patent/ZA941807B/xx unknown
- 1994-03-15 JP JP6044091A patent/JP2568474B2/ja not_active Expired - Lifetime
- 1994-03-15 AU AU57832/94A patent/AU668804B2/en not_active Expired
- 1994-08-29 US US08/298,479 patent/US5514650A/en not_active Expired - Lifetime
- 1994-10-03 UA UA95094151A patent/UA59329C2/uk unknown
-
1995
- 1995-06-29 HU HU95P/P00565P patent/HU211890A9/hu unknown
- 1995-09-13 BG BG99999A patent/BG63047B1/bg unknown
- 1995-09-14 FI FI954327A patent/FI109542B/fi not_active IP Right Cessation
- 1995-09-15 NO NO19953648A patent/NO318372B1/no not_active IP Right Cessation
-
1996
- 1996-10-28 US US08/741,645 patent/US5792746A/en not_active Expired - Lifetime
-
1997
- 1997-04-16 BR BR1100273-5A patent/BR1100273A/pt active IP Right Grant
-
1998
- 1998-07-20 HK HK98109267A patent/HK1008674A1/xx not_active IP Right Cessation
-
1999
- 1999-11-18 GR GR990402878T patent/GR3031872T3/el unknown
-
2000
- 2000-09-07 LV LVP-00-119A patent/LV12574B/en unknown
-
2001
- 2001-12-18 NL NL300076C patent/NL300076I2/nl unknown
-
2002
- 2002-01-03 LU LU90875C patent/LU90875I2/xx unknown
-
2005
- 2005-09-13 NO NO2005020C patent/NO2005020I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2005020I2 (no) | Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat | |
AU5669398A (en) | Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them | |
TR200200785T2 (tr) | 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri | |
AU2227992A (en) | Conformationally restricted biologically active peptides, methods for their production and uses thereof | |
UA43323C2 (uk) | Антибіотичні похідні глікопептидів, спосіб отримання та фармацевтична композиція | |
CA2272705A1 (en) | Fused bicyclic pyrimidine derivatives | |
MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
DE69631609D1 (en) | Tricyclische erythromycinderivate | |
RU92004562A (ru) | Новые цефалоспорины, имеющие в положении 7 замещенный оксииминный радикал, метод их получения и их использование в качестве медикаментов, фармацевтический состав на их основе | |
AU2886595A (en) | Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents | |
FI961717A (fi) | Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi | |
DE69118126D1 (de) | Derivate von 10,11,12,13-tetra-hydrodesmycosin, Verfahren zu ihrer Herstellung, und ihre Verwendung zur Herstellung von Arzneimitteln | |
GR920100423A (el) | Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος. | |
ZA912180B (en) | Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them | |
AU8060391A (en) | Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents | |
IL117302A (en) | Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same | |
GB9018263D0 (en) | Tricyclo compounds,processes for their production and pharmaceutical compositions containing the same |